Harrow Health, Inc.HROWNASDAQ
LOADING
|||
Switch Symbol:
Revenue Growth Under Pressure
Trending lower, above historical average.
Left:
||||
Year-over-year revenue growth rate
Latest
12.39%
↑ 23% above average
Average (39q)
10.08%
Historical baseline
Range
High:78.65%
Low:-31.79%
CAGR
-2.3%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | 12.39% |
| Q2 2025 | 33.27% |
| Q1 2025 | -28.43% |
| Q4 2024 | 35.68% |
| Q3 2024 | 0.65% |
| Q2 2024 | 41.50% |
| Q1 2024 | -4.86% |
| Q4 2023 | 6.10% |
| Q3 2023 | 2.38% |
| Q2 2023 | 28.22% |
| Q1 2023 | 28.40% |
| Q4 2022 | -10.93% |
| Q3 2022 | -2.14% |
| Q2 2022 | 5.44% |
| Q1 2022 | 9.57% |
| Q4 2021 | 7.89% |
| Q3 2021 | 3.18% |
| Q2 2021 | 17.43% |
| Q1 2021 | 5.81% |
| Q4 2020 | 1.36% |
| Q3 2020 | 78.65% |
| Q2 2020 | -31.79% |
| Q1 2020 | -6.24% |
| Q4 2019 | -1.18% |
| Q3 2019 | -5.63% |
| Q2 2019 | 9.98% |
| Q1 2019 | 7.96% |
| Q4 2018 | 6.01% |
| Q3 2018 | 3.42% |
| Q2 2018 | 17.13% |
| Q1 2018 | 20.83% |
| Q4 2017 | 13.17% |
| Q3 2017 | -5.45% |
| Q2 2017 | 12.47% |
| Q1 2017 | 5.25% |
| Q4 2016 | 19.17% |
| Q3 2016 | -0.94% |
| Q2 2016 | 12.01% |
| Q1 2016 | 25.06% |
| Q4 2015 | 30.56% |